(Q45181630)

10 December 2017

title

Development of peptide vaccines inducing production of neutralizing antibodies against HIV-1 viruses in HLA-DQ6 mice (English)

1 reference

10 December 2017

Takahashi A

1

1 reference

10 December 2017

Ogasawara K

2

1 reference

10 December 2017

Matsuki N

3

1 reference

10 December 2017

Fujinaga K

4

1 reference

10 December 2017

Nakaya T

5

1 reference

10 December 2017

Ikuta K

6

1 reference

10 December 2017

Auwanit W

7

1 reference

10 December 2017

Honda M

8

1 reference

10 December 2017

Fukui Y

9

1 reference

10 December 2017

Sasazuki T

10

1 reference

10 December 2017

Iwabuchi K

11

1 reference

10 December 2017

Onoé K

12

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

10 December 2017

1 reference

10 December 2017

volume

16

1 reference

10 December 2017

issue

16

1 reference

10 December 2017

page(s)

1537-1543

1 reference

Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900042-5

7 January 2021

Neutralization of Divergent HIV-1 Isolates by Conformation-Dependent Human Antibodies to Gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900042-5

7 January 2021

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900042-5

7 January 2021

Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900042-5

7 January 2021

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900042-5

7 January 2021

Promiscuous and allele-specific anchors in HLA-DR-binding peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900042-5

7 January 2021

Determination of amino acids on agretopes of pigeon cytochrome c-related peptides specifically bound to I-A allelic products

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900042-5

7 January 2021

Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900042-5

7 January 2021

Mice lacking MHC class II molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900042-5

7 January 2021

Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900042-5

7 January 2021

Motifs and supermotifs for MHC class II binding peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900042-5

7 January 2021

A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900042-5

7 January 2021

Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900042-5

7 January 2021

Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900042-5

7 January 2021

A promiscuous T cell hybridoma restricted to various I-A molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900042-5

7 January 2021

Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900042-5

7 January 2021

10.1016/S0264-410X(98)00042-5

Identifiers

DOI

1 reference

10 December 2017

1 reference